IV hydration therapy includes administer intravenous fluids for hydration and electrolyte replenishment. These therapies are gaining popularity for treatment of dehydration caused due to gastrointestinal illnesses, hangovers or excessive alcohol consumption. IV hydration involves administering normal saline, or balanced electrolyte solutions containing sodium, potassium, calcium and other key minerals into veins. The procedure helps restore hydration and replenish fluids and electrolytes in the body faster than oral rehydration. Rise in trend of weekend binge drinking especially among youth has led to increasing cases of dehydration, driving the demand for IV hydration therapy in Europe.
The Global Europe IV Hydration Therapy Market is estimated to be valued at US$ 301.46 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Europe IV Hydration Therapy are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals, Abcam plc. Thermo Fisher Scientific dominates the Europe IV hydration therapy market with wide range of IV solutions.
Demand for IV hydration therapy is growing due increasing weekend binge drinking especially among youth and rising awareness about the benefits of IV therapy. Growing prevalence of lifestyle diseases including diabetes and dietary changes have contributed to rising cases of dehydration.
Advancements in IV fluid formulations with optimum balance of electrolytes is helping restore hydration faster. Development of portable IV hydration therapy kits and products for home use is another technological trend gaining traction in the market.
Market Trends
Personalized IV fluid therapy is emerging as a key trend in the Europe IV hydration therapy market. Based on individual fluid and electrolyte requirements, IV solutions with customized formulations are being developed. This ensures ideal rehydration with minimum side effects.
Point of care IV hydration centers have witnessed rapid growth across major European countries. These centers provide on demand IV therapies without need for long wait times or hospital visits. The trend is being driven by growing preference for convenience and instant hydration.
Market Opportunities
Rising health awareness and focus on preventive healthcare is expected to boost demand for IV therapy as hydration boost. Marketing IV hydration therapy as vital nutritional IV can open new revenue streams.
Launch of advanced home IV kits for hangover recovery and overnight rehydration therapy presents lucrative opportunities. This will help reach wider audience and improve accessibility of IV therapy.
Impact of COVID-19 on Europe IV Hydration Therapy Market
The COVID-19 pandemic has severely impacted the growth of Europe IV hydration therapy market size. Strict lockdowns imposed across nations led to hospital staff focusing only on COVID-19 cases, resulting in postponing of general IV therapies. Outpatient clinics witnessed a sharp decline in number of visits due to fear of infection. Manufacturers faced issues in procuring raw materials and distributing finished products owing to closed borders and restrictions on transportation. It is estimated that market revenue declined by over 15% in 2020.
However, post pandemic many patients are realizing importance of maintaining good immunity and hydration levels. They are increasingly opting for IV hydration therapy performed at home or smaller clinics to boost their health. Market players are launching affordable home therapy kits including ready-to-use IV solution bags andeasy application instructions. They are also partnering with e-commerce portals and telemedicine services for doorstep delivery of products. The pandemic has accelerated shift towards remote and digital healthcare models. It is expected that development of advanced apps for self-administration and remote monitoring by doctors will further drive market growth in coming years.
Geographical Regions
United Kingdom holds the largest share of over 25% in terms of revenue generated from Europe IV hydration therapy market. Well established healthcare infrastructure, high awareness among population regarding health benefits of IV therapy and presence of many clinics offering these services have contributed to its leading position. Germany occupies second position with around 20% market share. Rising lifestyle diseases, growing geriatric population demanding preventive treatments and favorable reimbursement policies are fueling demand in the country. France has been witnessing steady growth and accounts for over 15% revenue share owing to expanding outpatient clinics especially in major cities.
Fastest Growing Regional Market for Europe IV Hydration Therapy
Spain's IV hydration therapy market is witnessing fastest growth and projected to expand at a CAGR of around 8% during forecast period. Young demographic profile, increasing health consciousness and rising disposable income levels are driving more people to opt for IV hydration sessions. Further, new companies are entering Spain offering competitive packages and making therapies affordable for middle-income group as well. Moreover, booming medical tourism industry is attracting international patients to clinics providing IV therapies. These factors together are propelling Spain to emerge as the fastest developing regional market for IV hydration in Europe.
Explore Our More Blogs Here: https://www.pressreleasebulletin.com/europe-iv-hydration-therapy-market-set-for-robust-growth-due-to-rising-geriatric-population/
